Real life stories from patients with the EVO Visian ICL family of lenses

Real life stories from patients with the EVO Visian ICL family of lenses
"My life is definitely simpler now, on and off the pitch, EVO ICL has improved my eyesight to even better than 20/20, which is amazing. Having that precision vision has really been life changing."
Lucy Bronze, MBE
Professional International Footballer

Eve Torres Gracie
Jiu Jitsu Instructor

Phil Torres
Entomologist, TV Show Host

The thing that I love about ICLs is that they are putting a lens in there that can be removed.
Jennifer Puno
Web Designer
Read the full storyReady to Discover Visual Freedom with EVO ICL? Find a Provider Today

Andrew Oxenham
Photographer

I would never be able to just wake up and go, and now I can literally just roll out of bed and go straight to the farmers market.
Sara Tso
Chef
Read the full storyVisian ICL feels like I am finally experiencing life the way it is meant to be experienced; there are no more barriers between me and the world.

Gayane Khechoomian
Attorney
I don’t say this a lot, but it really did change my life. Vision is important to me… and I’m not someone that likes to be encumbered by anything.

Jennifer Van Dijk
Pilot
Sports are difficult with glasses. Contacts are better, but I still have to worry about them falling out at the worst possible time. Since getting Visian ICL, I don’t even think about those things anymore.

James Robinson
Computer Programmer
In the past, I would make short term decisions that would be cheaper and would fix the problem short term. This (Visian ICL) fixed the problem long term.

Ashley Acda
Teacher
Important Safety Information
The ICL is designed for the correction/reduction of myopia in patients, 21 to 60 years of age, ranging from -0.5 D to -20.0 D with or without astigmatism up to 6.0 D and the correction/reduction of hyperopia in patients, from 21 to 45 years of age, with hyperopia ranging from +0.5 D to +16.0 D with or without astigmatism up to 6.0 D. In order to be sure that your surgeon will use a ICL with the most adequate power for your eye, your nearsightedness, farsightedness and astigmatism should be stable for at least a year before undergoing eye surgery. ICL surgery may improve your vision without eyeglasses or contact lenses. ICL surgery does not eliminate the need for reading glasses, even if you have never worn them before. ICL represents an alternative to other refractive surgeries including, laser assisted in situ keratomileusis (LASIK), photorefractive keratectomy (PRK), incisional surgeries, or other means to correct your vision such as contact lenses and eye glasses. Implantation of an ICL is a surgical procedure, and as such, carries potentially serious risks. The following represent potential complications/adverse reactions reported in conjunction with refractive surgery in general: additional surgeries, cataract formation, loss of best corrected vision, raised pressure inside the eye, loss of cells on the innermost surface of the cornea, conjunctival irritation, acute corneal swelling, persistent corneal swelling, endophthalmitis (total eye infection), significant glare and/or halos around lights, hyphaema (blood in the eye), hypopyon (pus in the eye), eye infection, ICL dislocation, macular oedema, non-reactive pupil, pupillary block glaucoma, severe inflammation of the eye, iritis, uveitis, vitreous loss and corneal transplant. Before considering ICL surgery you should have a complete eye examination and talk with your eye care professional about ICL surgery, especially the potential benefits, risks, and complications. You should discuss the time needed for healing after surgery.
Select Your Region
Latin America
References
1. Packer M. The Implantable Collamer Lens with a central port: review of the literature. Clin Ophthalmol. 2018;12:2427-2438.
2. Martínez-Plaza E, López-Miguel A, López-De La Rosa A, et al. Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life, Am J Ophthalmol 2021;226: 117-125.
3. Packer M. Evaluation of the EVO/EVO+ Sphere and Toric Visian ICL: Six Month Results from the United States Food and Drug Administration Clinical Trial. Clin Ophthalmol. 2022;16:1541-53.
4. Parkhurst GD. A prospective comparison of phakic collamer lenses and wavefront-optimized laser-assisted in situ keratomileusis for correction of myopia. Clin Ophthalmol. 2016;10:1209-1215.
5. Zhang H, Deng Y, Ma K, Yin H, Tang J. Analysis on the changes of objective indicators of dry eye after implantable collamer lens (ICL) implantation surgery. Graefes Arch Clin Exp Ophthalmol. 2024 Jul;262(7):2321-2328.
6. Albo C, Nasser T, Szynkarski DT, Nguyen N, Mueller B, Libfraind L, Parkhurst G. A Comprehensive Retrospective Analysis of EVO/EVO+ Implantable Collamer Lens: Evaluating Refractive Outcomes in the Largest Single Center Study of ICL Patients in the United States. Clin Ophthalmol. 2024 Jan 9;18:69-78.